Final report on pharmaceutical sector inquiry: Self-assessment is the best medicine

    July 2009

    The European Commission has released the Final Report on its inquiry into the pharmaceutical sector, confirming many of the concerns identified in its Preliminary Findings last November, but softening the harshest criticism of the industry.

    The Commission believes that pharmaceutical companies are harming the market by blocking innovation and delaying the entry of new drugs, ultimately threatening European citizens' well-being. The Authority is tightening its scrutiny of the way both originator and generic pharmaceutical manufacturers manage intellectual property rights, and will take action against behaviour it deems anticompetitive.